Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

Share Price is delayed by 15 minutes
Get Live Data
91.50    0.00 (0.00%)
Bid:
91.40
Ask:
91.60
Spread: 0.20 (0.219%)
Market Cap: £541.75m
BSIF Live PriceLast checked at - London Stock Exchange

Intraday Bluefield Solar Share Chart

Form 8.3

12 Feb 2026 15:25

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bluefield Solar Income Fund Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

0.01p ordinary – 592,080,033

(ISIN: GG00BB0RDB98)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

6,058,327

1.02%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

6,058,327

1.02%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

N/A

N/A

N/A

N/A

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.01p ordinary

CFD

Reducing a long position

200,000

GBP 0.7610

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.

If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:

12 February 2026

Contact name:

Mary Merrigan

Telephone number:

+1 617 778 7775

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260212174939/en/

Copyright Business Wire 2026

Date   Source Headline
6th Nov 20252:39 pmEQSForm 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
6th Nov 20251:41 pmGNWForm 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 202512:56 pmRNSForm 8.3 - Bluefield Solar Income Fund - Replace
6th Nov 202512:56 pmRNSForm 8.3 - Bluefield Solar Income Fund - Replace
6th Nov 202512:16 pmGNWMan Group PLC : Form 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 202512:00 pmRNSForm 8.3 - Bluefield Solar Income Fund Limited
6th Nov 202510:21 amRNSForm 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 202510:15 amRNSForm 8.5 (EPT/RI) -Bluefield Solar Income Fund Ltd
5th Nov 20255:38 pmRNSForm 8.3 -Bluefield Solar Income Fund Ltd
5th Nov 20252:44 pmRNSForm 8.3 - Bluefield Solar Income Fund Limited
5th Nov 20259:47 amRNSForm 8.3 - Bluefield Solar Income Fund Ltd
5th Nov 20257:00 amRNSStrategic Review and Start of Formal Sale Process
4th Nov 20259:03 amRNSDirector Declaration
21st Oct 20257:40 amRNSFourth Interim Dividend - Replacement
21st Oct 20257:02 amRNSChanges to Director Roles and Responsibilities
21st Oct 20257:01 amRNSFourth Interim Dividend
21st Oct 20257:00 amRNSAnnual Report for the Year Ended 30 June 2025
2nd Oct 20257:00 amRNSNotice of Full Year Results
12th Sep 20252:30 pmRNSHolding(s) in Company
19th Aug 20257:00 amRNSUnaudited NAV, Dividend & Director Role Changes
18th Aug 20257:00 amRNSSigning of Phase Three of Strategic Partnership
30th May 20257:00 amRNSRevolving Credit Facility Reduced and Extended
15th May 20257:00 amRNSUnaudited NAV and Second Interim Dividend
27th Feb 20257:00 amRNSInterim Results to 31 December 2024
24th Feb 20257:00 amRNSCompletion of circa £300 million refinancing
19th Feb 202511:02 amRNSChange to Director Roles and Responsibilities
3rd Feb 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSNotice of Interim Results
28th Jan 20257:00 amRNSFirst Interim Dividend
20th Jan 202512:39 pmRNSHolding(s) in Company
17th Jan 202511:37 amRNSHolding(s) in Company
16th Jan 20254:27 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:01 amRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.